The Leading Brand of Psychobiotics in Asia
Psycho-biotics for a Happy Life

Prof. Ying-Chieh Tsai is an international expert in probiotics. With the main core to profound research in probiotics, he assembled both domestic and international biomedical science researchers to build an international pharmaceutical business. Bened Biomedical is the first psychobiotic brand to ever develop in Asia. With a solid research foundation and flawless quality control principle, we have built the perfect products to take care of your physical and mental health!

Our Story

Bened Biomedical Co., Ltd. was founded in 2015 in Taipei, Taiwan, as a spin-out company from National Yang-Ming University (NYMU). It focuses on advanced technologies and products in microbiome-based therapy for neuropsychological, allergic, immunological, metabolic, and aging-related disorders. The ground work originated as an academia-industrial special project sponsored by the Ministry of Economic Affairs and was executed by Prof. Tsai, Ying-Chieh, the founder of Bened and a distinguished professor of the Institute of Biochemistry and Molecular Biology of NYMU and the director of Microbiome Research Center of NYMU. Bened has inherited this deep root and built a strong alliance with NYMU based on technical research and development by leveraging the university’s rich research resources. Meanwhile, Bened is the main sponsor enterprise for the Microbiome Research Center at NYMU and will further contribute a portion of its annual sales revenue to help strengthen the center’s impacts on academic research and the industry. A milestone has been successfully completed to demonstrate the efficacy of Psychobiotic PS128, along with a series of upcoming clinical studies scheduled across both human and animal health application. Our vision is to develop functional probiotic strains that can alter human microbiome to prevent and treat human diseases. We chose the name “Bened”, which means “good blessing” in Latin, and expect the company to deliver blessing through our products and maximize the benefit to the global community. 「Honor God, Serve The World」is our ultimate mission.



A CSR project “Par Par Go” targeting PD (Parkinson’s disease) was launched.


PS128 patents in EU, JPN and TW were granted.

A CSR project “Happy Little Stars” on ASD (Autism) was initiated to benefit huneds of children


Bened Biomed Co., Ltd. was founded and merged with KSK and Uni-Asia in March.


The first PS128® psychobiotics product “Good Mood” was announced and launched in October.


Shanghai Uni-Asia Co., Ltd. was established in China.


An academia-industrial special project sponsored by the Ministry of Economic Affairs was started in April.



Kei-Sei-Ken Biotech (aka KSK) was founded.


To develop best-of-breed psychobiotics which can effectively prevent and alleviate mental disorders for the global community.


Company Snapshot

Scientific and Business Collaboration Opportunities

Bened Biomedical is always open to collaborating with scientific partners. Our core interests are in both mechanical and clinical aspects of the microbiome gut-brain axis. Our research interests include studies on depression, anxiety, Parkinson's disease, autism, as well as psycho-neurological and brain-related diseases.

Bened Biomedical develops, manufactures, and distributes probiotics. We also continue to look for partners interested in rebranding and distributing private-label products domestically, regionally, or globally.

Feel free to contact us if you are interested in collaboration.